Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
05 2019
Historique:
received: 13 07 2018
accepted: 26 11 2018
pubmed: 30 11 2018
medline: 29 7 2020
entrez: 30 11 2018
Statut: ppublish

Résumé

Information on the prevalence and course of post-stroke cognitive impairment in young stroke patients is limited. The aim was to assess a consecutive sample of acute young ischaemic stroke patients (18-55 years) for the presence and development of neuropsychological deficits. Patients prospectively underwent a comprehensive clinical and cognitive assessment, examining general cognitive function, processing speed, attention, flexibility/executive function and word fluency within the first 3 weeks after hospital admission (median assessment at day 6) and at a 3 months' follow-up (FU). Cognitive dysfunction was defined in comparison to age-standardized published norms. At baseline (N = 114), deficits were highly prevalent in processing speed (56.0%), flexibility/executive function (49.5%), attention (46.4%) and general cognitive function (42.1%). These frequencies were comparable for those with FU assessment (N = 87). In most domains, cognitive performance improved within 3 months, except for word fluency. However, in about one-third of patients, cognitive deficits (as defined by 1.5 standard deviations below the standardized mean) were still present 3 months after stroke. At FU, 44.0% were impaired in the domain flexibility/executive function, 35.0% in processing speed and 30.0% in attention. The high prevalence of cognitive deficits in acute young patients with ischaemic stroke highlights the importance of early post-stroke cognitive assessment to capture a patient's dysfunction in a comprehensive manner and to offer adequate rehabilitation. The role of factors which promote neuropsychological deficits needs further exploration.

Sections du résumé

BACKGROUND AND PURPOSE
Information on the prevalence and course of post-stroke cognitive impairment in young stroke patients is limited. The aim was to assess a consecutive sample of acute young ischaemic stroke patients (18-55 years) for the presence and development of neuropsychological deficits.
METHODS
Patients prospectively underwent a comprehensive clinical and cognitive assessment, examining general cognitive function, processing speed, attention, flexibility/executive function and word fluency within the first 3 weeks after hospital admission (median assessment at day 6) and at a 3 months' follow-up (FU). Cognitive dysfunction was defined in comparison to age-standardized published norms.
RESULTS
At baseline (N = 114), deficits were highly prevalent in processing speed (56.0%), flexibility/executive function (49.5%), attention (46.4%) and general cognitive function (42.1%). These frequencies were comparable for those with FU assessment (N = 87). In most domains, cognitive performance improved within 3 months, except for word fluency. However, in about one-third of patients, cognitive deficits (as defined by 1.5 standard deviations below the standardized mean) were still present 3 months after stroke. At FU, 44.0% were impaired in the domain flexibility/executive function, 35.0% in processing speed and 30.0% in attention.
CONCLUSIONS
The high prevalence of cognitive deficits in acute young patients with ischaemic stroke highlights the importance of early post-stroke cognitive assessment to capture a patient's dysfunction in a comprehensive manner and to offer adequate rehabilitation. The role of factors which promote neuropsychological deficits needs further exploration.

Identifiants

pubmed: 30489673
doi: 10.1111/ene.13879
pmc: PMC6491967
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

727-732

Informations de copyright

© 2018 The Authors European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

J Clin Exp Neuropsychol. 2000 Aug;22(4):518-28
pubmed: 10923061
Stroke. 2001 May;32(5):1091-8
pubmed: 11340215
Eur J Neurol. 2002 May;9(3):269-75
pubmed: 11985635
Arch Phys Med Rehabil. 2003 Oct;84(10):1499-504
pubmed: 14586918
Clin Neurol Neurosurg. 2005 Aug;107(5):385-92
pubmed: 16023532
J Int Neuropsychol Soc. 2005 Nov;11(7):795-806
pubmed: 16519259
Arch Clin Neuropsychol. 2007 Feb;22(2):133-42
pubmed: 17169527
Stroke. 2009 Apr;40(4):1195-203
pubmed: 19246709
Lancet Neurol. 2009 Nov;8(11):1006-18
pubmed: 19782001
Cerebrovasc Dis. 2010;29(5):415-23
pubmed: 20203483
Stroke. 2011 Apr;42(4):883-8
pubmed: 21330625
Lancet. 2011 May 14;377(9778):1693-702
pubmed: 21571152
J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):316-21
pubmed: 22952327
Neurology. 2012 Oct 23;79(17):1781-7
pubmed: 23054237
JAMA. 2013 Mar 20;309(11):1136-44
pubmed: 23512060
Stroke. 2013 Jun;44(6):1621-8
pubmed: 23652272
Rev Neurol (Paris). 2013 Oct;169(10):757-64
pubmed: 24035574
NeuroRehabilitation. 2014;34(2):305-12
pubmed: 24401826
Stroke. 2014 Apr;45(4):1157-60
pubmed: 24578210
BMC Neurol. 2014 Mar 22;14:55
pubmed: 24655479
Nat Rev Neurol. 2014 Jun;10(6):315-25
pubmed: 24776923
Cerebrovasc Dis. 2014;37(5):376-81
pubmed: 24970603
Cerebrovasc Dis. 2014;38(4):284-9
pubmed: 25412708
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):554-61
pubmed: 25534371
Eur J Neurol. 2016 May;23(5):940-7
pubmed: 26917058
J Am Heart Assoc. 2016 May 11;5(5):
pubmed: 27169549
Stroke. 2016 Oct;47(10):2450-5
pubmed: 27539302
Hypertension. 2016 Dec;68(6):e67-e94
pubmed: 27977393
J Hypertens. 2017 Jun;35(6):1263-1270
pubmed: 28169884
J Int Neuropsychol Soc. 2018 Feb;24(2):117-127
pubmed: 28791943
Int J Stroke. 2018 Apr;13(3):243-256
pubmed: 29189108
Eur Stroke J. 2016 Mar;1(1):28-40
pubmed: 31008265
Neurology. 1998 Aug;51(2):433-40
pubmed: 9710015

Auteurs

D Pinter (D)

Department of Neurology, Medical University of Graz, Graz, Austria.

C Enzinger (C)

Department of Neurology, Medical University of Graz, Graz, Austria.
Division of Neuroradiology, Vascular and Interventional Neuroradiology, Medical University of Graz, Graz, Austria.

T Gattringer (T)

Department of Neurology, Medical University of Graz, Graz, Austria.

S Eppinger (S)

Department of Neurology, Medical University of Graz, Graz, Austria.

K Niederkorn (K)

Department of Neurology, Medical University of Graz, Graz, Austria.

S Horner (S)

Department of Neurology, Medical University of Graz, Graz, Austria.

S Fandler (S)

Department of Neurology, Medical University of Graz, Graz, Austria.

M Kneihsl (M)

Department of Neurology, Medical University of Graz, Graz, Austria.

K Krenn (K)

Department of Neurology, Medical University of Graz, Graz, Austria.

G Bachmaier (G)

Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

F Fazekas (F)

Department of Neurology, Medical University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH